Heartburn drug Motilium should be restricted due to heart deaths, says medicines regulator

               Heartburn drug Motilium should be restricted due to heart deaths, says medicines regulator

      Around two million people were prescribed Motilium, also known as domperidone, for sickness and nausea symptoms, stomach conditions and heartburn. Now following a review at European level, the drug will be restricted for those with sickness and nausea only. […] The drug is widely prescribed by GPs for babies with severe reflux and can continue to be used in this way under caution and when the doctor has carefully calculated the dose according to the child's weight and is satisfied they do not have a heart condition, a spokesman for the drugs regulator said.

Disponível em: http://www.telegraph.co.uk/health/healthnews/10788459/Heartburn-drug-Motilium-should-be-restricted-due-to-heart-deaths-says-medicines-regulator.html. Acesso em: 26 abr. 2014.  

O texto trata de: